
Compugen Ltd.
CGENHealthcare|Biotechnology|IL
$1.96
+0.04 (+2.08%)
Tangible Book / Share
$0.94
Graham Number
$2.80
Cash / Share
$1.32
Ownership Breakdown
99.6%
Float
94.7M
Shares Outstanding
94.4M
Float Shares
Major Holders (1)
Combined: 2.1%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Bristol Myers Squibb Co | Corporation | 2.06% | 1,840,136 | Feb 14, 2025 | 13D/G |
Insider Trades (100)
Last 4 quarters: 666,375 acquired · 95,750 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Levine Zurit | SVP, Business Development | Jul 29, 2026 | AWARD | 18,000 | — | — | Form 4 |
| Levine Zurit | SVP, Business Development | Jul 29, 2026 | AWARD | 24,000 | $2.26 | $54.2K | Form 4 |
| Silberman David | Chief Financial Officer | Jul 29, 2026 | AWARD | 19,500 | — | — | Form 4 |
| Silberman David | Chief Financial Officer | Jul 29, 2026 | AWARD | 26,000 | $2.26 | $58.8K | Form 4 |
| Ophir Eran | director, officer: President and CEO | Jul 29, 2026 | AWARD | 200,000 | $2.26 | $452.0K | Form 4 |
| Cohen-Dayag Anat | director | Jul 29, 2026 | AWARD | 100,000 | $2.26 | $226.0K | Form 4 |
| Perry Eran | director | Jul 29, 2026 | AWARD | 7,500 | — | — | Form 4 |
| Perry Eran | director | Jul 29, 2026 | AWARD | 10,000 | $2.26 | $22.6K | Form 4 |
| Ferre Pierre | Chief Operating Officer | Jul 29, 2026 | AWARD | 70,000 | $4.00 | $280.0K | Form 4 |
| Kredo Russo Sharon | SVP, Research & Discovery | Jul 29, 2026 | AWARD | 18,000 | — | — | Form 4 |
| Kredo Russo Sharon | SVP, Research & Discovery | Jul 29, 2026 | AWARD | 24,000 | $2.26 | $54.2K | Form 4 |
| Livnat Savitzky Kinneret | director | Jul 29, 2026 | AWARD | 7,500 | — | — | Form 4 |
| Livnat Savitzky Kinneret | director | Jul 29, 2026 | AWARD | 10,000 | $2.26 | $22.6K | Form 4 |
| Hukkelhoven Mathias | director | Jul 29, 2026 | AWARD | 7,500 | — | — | Form 4 |
| Hukkelhoven Mathias | director | Jul 29, 2026 | AWARD | 10,000 | $2.26 | $22.6K | Form 4 |
| Halevy Gilead | director | Jul 29, 2026 | AWARD | 7,500 | — | — | Form 4 |
| Halevy Gilead | director | Jul 29, 2026 | AWARD | 10,000 | $2.26 | $22.6K | Form 4 |
| ZWEIFACH SANFORD S | director | Jul 29, 2026 | AWARD | 7,500 | — | — | Form 4 |
| ZWEIFACH SANFORD S | director | Jul 29, 2026 | AWARD | 10,000 | $2.26 | $22.6K | Form 4 |
| Mahler Michelle | Chief Medical Officer | Jul 29, 2026 | AWARD | 13,500 | — | — | Form 4 |
| Mahler Michelle | Chief Medical Officer | Jul 29, 2026 | AWARD | 18,000 | $2.26 | $40.7K | Form 4 |
| Levine Zurit | SVP, Business Development | Jul 9, 2026 | OPTION EX. | 1,875 | $0.83 | $1.6K | Form 4 |
| Levine Zurit | SVP, Business Development | Jul 9, 2026 | SELL | 1,875 | $2.50 | $4.7K | Form 4 |
| Levine Zurit | SVP, Business Development | Jul 9, 2026 | OPTION EX. | 1,875 | $0.83 | $1.6K | Form 4 |
| Levine Zurit | SVP, Business Development | Apr 24, 2026 | OPTION EX. | 2,000 | $1.15 | $2.3K | Form 4 |
| Levine Zurit | SVP, Business Development | Apr 24, 2026 | OPTION EX. | 2,000 | $1.15 | $2.3K | Form 4 |
| Levine Zurit | SVP, Business Development | Apr 24, 2026 | SELL | 2,000 | $3.20 | $6.4K | Form 4 |
| Ophir Eran | director, officer: President and CEO | Apr 24, 2026 | OPTION EX. | 5,000 | $0.83 | $4.1K | Form 4 |
| Ophir Eran | director, officer: President and CEO | Apr 24, 2026 | OPTION EX. | 5,000 | $0.83 | $4.1K | Form 4 |
| Ophir Eran | director, officer: President and CEO | Apr 24, 2026 | SELL | 5,000 | $3.20 | $16.0K | Form 4 |
| Ophir Eran | director, officer: President and CEO | Apr 14, 2026 | OPTION EX. | 5,000 | $0.83 | $4.1K | Form 4 |
| Ophir Eran | director, officer: President and CEO | Apr 14, 2026 | OPTION EX. | 5,000 | $0.83 | $4.1K | Form 4 |
| Ophir Eran | director, officer: President and CEO | Apr 14, 2026 | SELL | 5,000 | $2.90 | $14.5K | Form 4 |
| Levine Zurit | SVP, Business Development | Apr 14, 2026 | OPTION EX. | 2,000 | $1.15 | $2.3K | Form 4 |
| Levine Zurit | SVP, Business Development | Apr 14, 2026 | OPTION EX. | 2,000 | $1.15 | $2.3K | Form 4 |
| Levine Zurit | SVP, Business Development | Apr 14, 2026 | SELL | 2,000 | $2.80 | $5.6K | Form 4 |
| Levine Zurit | SVP, Business Development | Apr 10, 2026 | OPTION EX. | 2,000 | $1.15 | $2.3K | Form 4 |
| Levine Zurit | SVP, Business Development | Apr 10, 2026 | OPTION EX. | 2,000 | $1.15 | $2.3K | Form 4 |
| Levine Zurit | SVP, Business Development | Apr 10, 2026 | OPTION EX. | 1,125 | $0.83 | $932.85 | Form 4 |
| Levine Zurit | SVP, Business Development | Apr 10, 2026 | SELL | 3,125 | $2.56 | $8.0K | Form 4 |
| Levine Zurit | SVP, Business Development | Apr 10, 2026 | OPTION EX. | 1,125 | $0.83 | $932.85 | Form 4 |
| Levine Zurit | SVP, Business Development | Apr 8, 2026 | OPTION EX. | 1,000 | $1.15 | $1.1K | Form 4 |
| Levine Zurit | SVP, Business Development | Apr 8, 2026 | OPTION EX. | 1,000 | $1.15 | $1.1K | Form 4 |
| Levine Zurit | SVP, Business Development | Apr 8, 2026 | OPTION EX. | 4,375 | $0.83 | $3.6K | Form 4 |
| Levine Zurit | SVP, Business Development | Apr 7, 2026 | OPTION EX. | 2,500 | $0.83 | $2.1K | Form 4 |
| Levine Zurit | SVP, Business Development | Apr 8, 2026 | SELL | 5,375 | $2.42 | $13.0K | Form 4 |
| Levine Zurit | SVP, Business Development | Apr 7, 2026 | SELL | 2,500 | $2.30 | $5.8K | Form 4 |
| Levine Zurit | SVP, Business Development | Apr 7, 2026 | OPTION EX. | 2,500 | $0.83 | $2.1K | Form 4 |
| Levine Zurit | SVP, Business Development | Apr 8, 2026 | OPTION EX. | 4,375 | $0.83 | $3.6K | Form 4 |
| Levine Zurit | SVP, Business Development | Apr 1, 2026 | OPTION EX. | 1,000 | $1.15 | $1.1K | Form 4 |
| Levine Zurit | SVP, Business Development | Apr 1, 2026 | OPTION EX. | 1,000 | $1.15 | $1.1K | Form 4 |
| Levine Zurit | SVP, Business Development | Apr 1, 2026 | OPTION EX. | 2,500 | $0.83 | $2.1K | Form 4 |
| Levine Zurit | SVP, Business Development | Apr 1, 2026 | SELL | 3,500 | $2.20 | $7.7K | Form 4 |
| Levine Zurit | SVP, Business Development | Apr 1, 2026 | OPTION EX. | 2,500 | $0.83 | $2.1K | Form 4 |
| Ophir Eran | director, officer: President and CEO | Apr 1, 2026 | OPTION EX. | 5,625 | $0.83 | $4.7K | Form 4 |
| Ophir Eran | director, officer: President and CEO | Apr 1, 2026 | OPTION EX. | 5,625 | $0.83 | $4.7K | Form 4 |
| Ophir Eran | director, officer: President and CEO | Apr 1, 2026 | SELL | 5,625 | $2.21 | $12.4K | Form 4 |
| Levine Zurit | SVP, Business Development | Mar 26, 2026 | OPTION EX. | 11,875 | $0.83 | $9.8K | Form 4 |
| Levine Zurit | SVP, Business Development | Mar 26, 2026 | SELL | 11,875 | $2.04 | $24.2K | Form 4 |
| Levine Zurit | SVP, Business Development | Mar 26, 2026 | OPTION EX. | 11,875 | $0.83 | $9.8K | Form 4 |
| Hukkelhoven Mathias | director | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Hukkelhoven Mathias | director | Mar 18, 2026 | OTHER | 35,000 | $3.09 | $108.2K | Form 4 |
| Hukkelhoven Mathias | director | Mar 18, 2026 | OTHER | 10,000 | $1.15 | $11.5K | Form 4 |
| Hukkelhoven Mathias | director | Mar 18, 2026 | OTHER | 8,000 | $1.69 | $13.5K | Form 4 |
| Hukkelhoven Mathias | director | Mar 18, 2026 | OTHER | 12,000 | $1.97 | $23.6K | Form 4 |
| Hukkelhoven Mathias | director | Mar 18, 2026 | OTHER | 10,000 | $1.46 | $14.6K | Form 4 |
| Holcomb Michele | director | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Holcomb Michele | director | Mar 18, 2026 | OTHER | 20,000 | $1.76 | $35.2K | Form 4 |
| Halevy Gilead | director | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Halevy Gilead | director | Mar 18, 2026 | OTHER | 35,000 | $3.85 | $134.8K | Form 4 |
| Halevy Gilead | director | Mar 18, 2026 | OTHER | 10,000 | $3.24 | $32.4K | Form 4 |
| Halevy Gilead | director | Mar 18, 2026 | OTHER | 10,000 | $14.40 | $144.0K | Form 4 |
| Halevy Gilead | director | Mar 18, 2026 | OTHER | 10,000 | $6.45 | $64.5K | Form 4 |
| Halevy Gilead | director | Mar 18, 2026 | OTHER | 10,000 | $1.15 | $11.5K | Form 4 |
| Halevy Gilead | director | Mar 18, 2026 | OTHER | 8,000 | $1.69 | $13.5K | Form 4 |
| Halevy Gilead | director | Mar 18, 2026 | OTHER | 12,000 | $1.97 | $23.6K | Form 4 |
| Halevy Gilead | director | Mar 18, 2026 | OTHER | 10,000 | $1.46 | $14.6K | Form 4 |
| Ferre Pierre | Chief Operating Officer | Mar 18, 2026 | OTHER | 100,000 | $6.45 | $645.0K | Form 4 |
| Ferre Pierre | Chief Operating Officer | Mar 18, 2026 | OTHER | 65,000 | $5.00 | $325.0K | Form 4 |
| Ferre Pierre | Chief Operating Officer | Mar 18, 2026 | OTHER | 65,000 | $3.00 | $195.0K | Form 4 |
| Ferre Pierre | Chief Operating Officer | Mar 18, 2026 | OTHER | 70,000 | $4.00 | $280.0K | Form 4 |
| Cohen-Dayag Anat | director | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Cohen-Dayag Anat | director | Mar 18, 2026 | OTHER | 100,000 | $6.65 | $665.0K | Form 4 |
| Cohen-Dayag Anat | director | Mar 18, 2026 | OTHER | 100,000 | $2.85 | $285.0K | Form 4 |
| Cohen-Dayag Anat | director | Mar 18, 2026 | OTHER | 120,000 | $3.15 | $378.0K | Form 4 |
| Cohen-Dayag Anat | director | Mar 18, 2026 | OTHER | 120,000 | $3.80 | $456.0K | Form 4 |
| Cohen-Dayag Anat | director | Mar 18, 2026 | OTHER | 150,000 | $3.24 | $486.0K | Form 4 |
| Cohen-Dayag Anat | director | Mar 18, 2026 | OTHER | 150,000 | $14.40 | $2.2M | Form 4 |
| Cohen-Dayag Anat | director | Mar 18, 2026 | OTHER | 150,000 | $6.45 | $967.5K | Form 4 |
| Cohen-Dayag Anat | director | Mar 18, 2026 | OTHER | 150,000 | $1.15 | $172.5K | Form 4 |
| Cohen-Dayag Anat | director | Mar 18, 2026 | OTHER | 150,000 | $1.02 | $153.0K | Form 4 |
| Cohen-Dayag Anat | director | Mar 18, 2026 | OTHER | 195,000 | $1.69 | $329.6K | Form 4 |
| Cohen-Dayag Anat | director | Mar 18, 2026 | OTHER | 100,000 | $1.38 | $138.0K | Form 4 |
| ZWEIFACH SANFORD S | director | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| ZWEIFACH SANFORD S | director | Mar 18, 2026 | OTHER | 10,000 | $3.24 | $32.4K | Form 4 |
| ZWEIFACH SANFORD S | director | Mar 18, 2026 | OTHER | 10,000 | $14.40 | $144.0K | Form 4 |
| ZWEIFACH SANFORD S | director | Mar 18, 2026 | OTHER | 10,000 | $6.45 | $64.5K | Form 4 |
| ZWEIFACH SANFORD S | director | Mar 18, 2026 | OTHER | 10,000 | $1.15 | $11.5K | Form 4 |
| ZWEIFACH SANFORD S | director | Mar 18, 2026 | OTHER | 8,000 | $1.69 | $13.5K | Form 4 |
| ZWEIFACH SANFORD S | director | Mar 18, 2026 | OTHER | 12,000 | $1.97 | $23.6K | Form 4 |